During the past decade, Kaiser Permanente-Santa Rosa conducted 91 clinical trials. In the 10-year time frame, 91 clinical trials started and 82 clinical trials were completed, i.e. on average, 90.1% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 43 clinical trials were completed. i.e. 153.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente-Santa Rosa" #1 sponsor was "National Cancer Institute (NCI)" with 66 trials, followed by "SWOG Cancer Research Network" with 40 trials sponsored, "Alliance for Clinical Trials in Oncology" with 25 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 10 trials sponsored and "NSABP Foundation Inc" with 10 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente-Santa Rosa" #1 collaborator was "National Cancer Institute (NCI)" with 109 trials as a collaborator, "NRG Oncology" with 17 trials as a collaborator, "NCIC Clinical Trials Group" with 8 trials as a collaborator, "SWOG Cancer Research Network" with 8 trials as a collaborator and "Canadian Cancer Trials Group" with 7 trials as a collaborator. Other collaborators include 45 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente-Santa Rosa" are "Breast Cancer" (19 trials), "Colorectal Cancer" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials) and "Lung Cancer" (7 trials). Many other conditions were trialed in "Kaiser Permanente-Santa Rosa" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente-Santa Rosa" are "Drug" (134 trials), "Other" (108 trials), "Biological" (63 trials), "Procedure" (40 trials) and "Radiation" (32 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (57 trials), "Quality-of-Life Assessment" (42 trials), "Questionnaire Administration" (24 trials), "Carboplatin" (18 trials) and "Nivolumab" (17 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente-Santa Rosa" are 131 trials for "All" genders, 40 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Kaiser Permanente-Santa Rosa". undefined are not yet recruiting, 29 are recruiting, 78 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 59 completed trials in Kaiser Permanente-Santa Rosa, 4 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente-Santa Rosa, 5 "Phase 1" clinical trials were conducted, 61 "Phase 2" clinical trials and 110 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".